Fletcher Payne - Jun 27, 2022 Form 4 Insider Report for Aptose Biosciences Inc. (APTO)

Role
SR VP & Chief Fin. Officer
Signature
/s/ Janet Clennett as attorney-in-fact for Fletcher Payne
Stock symbol
APTO
Transactions as of
Jun 27, 2022
Transactions value $
$0
Form type
4
Date filed
6/28/2022, 04:16 PM
Next filing
Sep 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Common Stock Award $0 +1M $0.00 1M Jun 27, 2022 Common Stock 1M $0.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 50% of the options vest on 6/27/2023; the remaining options will vest in equal annual installments on June 27, 2024, June 27, 2025, and June 27, 2026.